Combined decongestant, Phenylpropanolamine Hydrochloride, and the antihistamine, Brompheniramine Maleate. The combination reduces the excessive nasopharyngeal secretion and diminishes inflammatory mucosal edema and congestion in the upper respiratory tract. The antihistaminic action of Brompheniramine Maleate reduces or abolishes the allergic response of nasal tissues. It is complemented by the mild vasoconstrictor action of Phenylpropanolamine Hydrochloride which provided a nasal decongestant effect.